PARI overexpression promotes genomic instability and pancreatic tumorigenesis

Keyphrases

• Binding Protein 33%
• Cancer Cell Proliferation 33%
• DNA Damage 100%
• DNA Damage Response Pathway 33%
• DNA Repair 33%
• DNA Replication 33%
• DT40 33%
• Genomic Instability 100%
• Homologous Recombination Pathway 33%
• Mouse Xenograft Model 33%
• Overexpression 100%
• Pancreatic Cancer 66%
• Pancreatic Cancer Cells 66%
• Pancreatic Ductal Adenocarcinoma 66%
• Pancreatic Tumor 33%
• Pancreatic Tumorigenesis 100%
• Phase Delay 33%
• Proliferation in Vitro 33%
• Sigma Phase 33%
• Targeted Therapy 33%
• Targets of Interest 33%
• Therapeutic Target 66%
• Treatment Options 33%
• Tumor Growth in Vivo 33%
• Tumor Protein p53 (TP53) 33%

Medicine and Dentistry

• Cancer Cell 75%
• Carcinogenesis 100%
• Cell Cycle 25%
• Cell Proliferation 25%
• DNA Damage 50%
• DNA Damage Response 25%
• DNA Repair 50%
• DNA Synthesis 25%
• Genomic Instability 100%
• Homologous Recombination 25%
• In Vitro 25%
• Pancreas Adenocarcinoma 50%
• Pancreas Cancer 100%
• Pancreas Tumor 25%
• Poly ADP Ribose Polymerase 25%
• Protein Binding 25%
• S Phase 25%
• Targeted Therapy 25%
• Tumor Progression 25%
• Upregulation 25%
• Xenograft 25%

Biochemistry, Genetics and Molecular Biology

• Aves 33%
• Binding Protein 33%
• Cancer Cell 100%
• Carcinogenesis 100%
• Cell Cycle 33%
• Cell Proliferation 33%
• DNA Damage 66%
• DNA Damage Response 33%
• DNA Repair 66%
• DNA Synthesis 33%
• Genome Instability 100%
• Homologous Recombination 33%
• KRAS 33%
• Poly ADP Ribose Polymerase 33%
• S Phase 33%
• Tumor Progression 33%
• Upregulation 33%